Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | 21,673 | reported | 09 Dec 2025 | tx 333+1,776,137−1,625,811 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 09 Dec 2025 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 2,552 | 701.51 USD | |
| 05 Dec 2025 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 3,715 | 0.00 USD | |
| 08 Dec 2025 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 1,906 | 712.94 USD | |
| 05 Dec 2025 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 18,315 | 0.00 USD | deriv |
| 16 Dec 2024 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 969 | 730.81 USD | |
| 06 Dec 2024 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 3,499 | 0.00 USD | |
| 09 Dec 2024 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 492 | 787.00 USD | |
| 06 Dec 2024 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 13,472 | 0.00 USD | deriv |
| 14 Feb 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 275 | 941.41 USD | |
| 14 Feb 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 375 | 950.45 USD | |
| 14 Feb 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 112 | 949.07 USD | |
| 14 Feb 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 150 | 948.70 USD | |
| 14 Feb 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 240 | 947.81 USD | |
| 14 Feb 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 95 | 945.81 USD | |
| 14 Feb 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 439 | 937.94 USD | |
| 14 Feb 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 226 | 938.13 USD | |
| 14 Feb 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 750 | 939.60 USD | |
| 14 Feb 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 4,261 | 940.44 USD | |
| 14 Feb 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 200 | 951.77 USD | |
| 14 Feb 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 2,691 | 943.51 USD | |
| 14 Feb 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 620 | 944.30 USD | |
| 09 Feb 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 23,125 | 381.40 USD | |
| 09 Feb 2024 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 16,341 | 951.68 USD | |
| 09 Feb 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 12,250 | 372.46 USD | |
| 09 Feb 2024 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 8,600 | 951.68 USD |